Techniques

We lead our industry by channeling robust expertise in immunoassays and cell-based assays to help our customers innovate more quickly and dependably through all phases of assay development, validation, and testing.

BioAgilytix is an industry leader in cell-based assay services. Over half of our scientific staff boast 10+ years of experience in performing cell-based assays and have cultured over 200 cell lines. Our scientists have experience with primary cells and transfected reporter-gene cell systems and can develop and validate cell-based assays under both GLP and GMP

Numerous drug modalities require virology methods to support preclinical and clinical bioanalysis. However, finding a laboratory with expertise in assays using viruses or viral components can be challenging. BioAgilytix provides development and validation of assays with virologic endpoints in support of vaccines, viral vectors, and therapeutics for treatment or prevention of diseases.

Molecular assays are commonly used in support of drug development, particularly with newer drug modalities such as cell and gene therapies. BioAgilytix leverages real-time polymerase chain reaction (also known as quantitative PCR or qPCR) and Droplet Digital PCR (ddPCR) as part of our extensive molecular technology suite to deliver bioanalytical solutions to support discovery, preclinical, and clinical programs.

Liquid Chromatography-Mass Spectrometry (LC/MS) is a technique that is used for separation, identification, and quantification of both unknown and known compounds as well as to elucidate the structure and chemical properties of different molecules. LC/MS is a common technique applied to the bioanalytical support and quantitation of large and small molecules during drug development.